Published in World J Gastroenterol on September 28, 2008
Inflammatory Bowel Disease. Dtsch Arztebl Int (2016) 1.56
Laparoscopic surgery for inflammatory bowel disease: does weight matter? Surg Endosc (2010) 0.89
A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn's disease. Tech Coloproctol (2015) 0.81
Management of abdominal and pelvic abscess in Crohn's disease. World J Gastrointest Endosc (2011) 0.78
Crohn's disease: Multimodality Imaging of Surgical Indications, Operative Procedures, and Complications. J Clin Imaging Sci (2011) 0.76
Successful management of a colo-duodenal fistula in a patient with Crohn's disease using a double lumen gastro-jejunostomy tube. Case Rep Gastroenterol (2014) 0.75
Surgery in Pediatric Crohn's Disease: Indications, Timing and Post-Operative Management. Pediatr Gastroenterol Hepatol Nutr (2017) 0.75
Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review. Int J Colorectal Dis (2017) 0.75
The effect of pre-operative optimization on post-operative outcome in Crohn's disease resections. Int J Colorectal Dis (2016) 0.75
Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J (1954) 20.09
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58
How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc (2000) 2.42
Nonsurgical treatment of abdominal or pelvic abscess in consecutive patients with Crohn's disease. Dig Liver Dis (2006) 2.22
Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology (1985) 2.21
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol (2008) 2.15
Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther (2006) 2.12
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology (2005) 2.05
Predicting outcome in severe ulcerative colitis. Gut (1996) 1.99
Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg (2007) 1.97
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
AGA technical review on perianal Crohn's disease. Gastroenterology (2003) 1.80
Management of Crohn's disease in adults. Am J Gastroenterol (1997) 1.65
Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg (2000) 1.57
Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum (2000) 1.52
Fistulas to the urinary system in Crohn's disease: clinical features and outcomes. Am J Gastroenterol (2002) 1.45
Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg (1991) 1.41
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther (2004) 1.33
Toxic megacolon. Lancet (1998) 1.31
Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol (2008) 1.30
Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol (2003) 1.29
Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol (2004) 1.27
Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum (2007) 1.22
Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years. Radiology (2002) 1.15
Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol (1988) 1.15
Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol (2001) 1.15
Gastrocolic fistulization in Crohn's disease: a case report and a review of the literature. Can J Surg (2000) 1.13
Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis (2003) 1.11
A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis (2006) 1.08
Life-threatening hemorrhage and exsanguination from Crohn's disease. Report of four cases. Dis Colon Rectum (1995) 1.08
Safety and efficacy of endoscopic balloon dilation for treatment of Crohn's disease strictures. Endoscopy (2006) 1.04
Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol (2005) 1.04
Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol (2006) 1.03
Surgical treatment of enterovesical fistulas in Crohn's disease. Dis Colon Rectum (1990) 1.00
Prospective study of the features, indications, and surgical treatment in 513 consecutive patients affected by Crohn's disease. Surgery (1997) 1.00
Growth retardation in pediatric Crohn's disease: pathogenesis and interventions. Inflamm Bowel Dis (2007) 0.98
Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol (1998) 0.96
Abscesses in Crohn's disease: outcome of medical versus surgical treatment. J Clin Gastroenterol (2001) 0.95
Acute surgical emergencies in inflammatory bowel disease. Am J Surg (2002) 0.94
Surgical and metabolic management of patients with external fistulas of the small intestine associated with Crohn's disease. World J Surg (1988) 0.90
Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics. Eur J Gastroenterol Hepatol (2006) 0.90
Diffuse jejunoileitis of Crohn's disease. Gut (1993) 0.89
Massive, life-threatening bleeding in Crohn's disease. Acta Chir Belg (2005) 0.86
Timing of ileocolonic resection for symptomatic Crohn's disease--the patient's view. Gut (1994) 0.86
Surgical management of entero and colocutaneous fistulae in Crohn's disease: 17 year's experience. Int J Colorectal Dis (2004) 0.85
Long-term follow-up in Crohn's disease. Mortality, morbidity, and functional status. Scand J Gastroenterol (1994) 0.84
Surgical treatment of anoperineal Crohn's disease: can abdominoperineal resection be predicted? J Am Coll Surg (1999) 0.82
Jejunoileal Crohn's disease: a case-control study. Gastroenterol Clin Biol (2004) 0.82
An historical overview of the treatment of Crohn's disease: why do we need biological therapies? Rev Gastroenterol Disord (2004) 0.82
Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: safe alternative to surgery. J Gastroenterol Hepatol (2007) 0.81
Severe gastrointestinal bleeding in Crohn's disease. Ann Ital Chir (2003) 0.81
Impact of preoperative infliximab use on postoperative infectious complications in ulcerative colitis: the price we have to pay? Inflamm Bowel Dis (2008) 0.80
The inflammatory bowel disease unit and the multidisciplinary team meeting. Colorectal Dis (2007) 0.80
Combined use of preoperative provocative angiography and highly selective methylene blue injection to localize an occult small-bowel bleeding site in a patient with Crohn's disease: report of a case. Dis Colon Rectum (2003) 0.79
Risk factors and indications for first surgery in Crohn's disease patients. Hepatogastroenterology (2008) 0.78
Abdominal wall abscesses in patients with Crohn's disease: clinical outcome. J Gastrointest Surg (2006) 0.77
Surgical therapy for Crohn's disease of the colon and rectum. Surg Clin North Am (1997) 0.76
Abdominal surgery for Crohn's disease during 30 years in Middle Norway. Hepatogastroenterology (2004) 0.76
[The Crohn-Colitis care unit: analysis of the first 3 years of activity]. Gac Sanit (2004) 0.76
[Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update]. Gastroenterol Hepatol (2006) 0.76
Joint position statement by “Sociedad Española de Patología Digestiva” (Spanish Society of Gastroenterology) and “Sociedad Española de Farmacología” (Spanish Society of Pharmacology) on biosimilar therapy for inflammatory bowel disease. Rev Esp Enferm Dig (2013) 2.09
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. Inflamm Bowel Dis (2013) 1.31
Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice. Med Sci Monit (2004) 1.07
Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process. PLoS One (2012) 0.95
Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy. Inflamm Bowel Dis (2008) 0.89
Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis. Digestion (2009) 0.86
Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU. Gastroenterol Hepatol (2013) 0.82
A new guidewire cannulation technique in ERCP: successful deep biliary access with triple-lumen sphincterotome and guidewire controlled by the endoscopist. Surg Endosc (2010) 0.80
Validation of a simplified clinical index to predict evolving patterns in Crohn's disease. Eur J Gastroenterol Hepatol (2002) 0.79
Author´s answer: Biosimilar therapy for inflammatory bowel disease. Rev Esp Enferm Dig (2014) 0.75
[Peripheral arterial thromboembolism in Crohn's disease]. Gastroenterol Hepatol (2012) 0.75
[Recommendations for patients with Crohn's disease starting treatment with adalimumab: a rapid guide]. Gastroenterol Hepatol (2009) 0.75
[Miliary tuberculosis in a patient with Crohn's disease]. Gastroenterol Hepatol (2011) 0.75
New contributions to consensus on biosimilars. Rev Esp Enferm Dig (2014) 0.75
Survey on the use of capsule endoscopy for patients with known or suspected Crohn's disease in Spain. Rev Esp Enferm Dig (2015) 0.75
[Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU]. Gastroenterol Hepatol (2013) 0.75
[Steroids: friends or foes?]. Gastroenterol Hepatol (2008) 0.75